A Review of Vaccine Efficacy Measures
DOI:
https://doi.org/10.17140/VROJ-4-110Keywords:
Vaccine efficacy, Effectiveness, Overall effectiveness, Vaccine-preventable disease incidence, Public health impactAbstract
To fully understand the assessments of vaccine efficacy and safety, the crucial information needed for regulatory approval, one
must understand the principles of vaccine epidemiology. In this review article, we go through some of the key concepts in vaccine
epidemiology.
Keywords
; ; ; ;
References
Plotkin S. History of vaccination. Proc Natl Acad Sci U S A. 2014; 111(34): 12283-12287. doi: 10.1073/pnas.1400472111
Riedel S. Edward Jenner and the history of smallpox and vaccination. Proc (Bayl Univ Med Cent). 2005; 18(1): 21-25. doi: 10.1080/08998280.2005.11928028
Weinberg GA, Szilagyi PG. Vaccine epidemiology: Efficacy, effectiveness, and the translational research roadmap. J Infect Dis. 2010; 201(11): 1607-1610. doi: 10.1086/652404
Hsu JL. A brief history of vaccines: Smallpox to the present. S D Med. 2013; Spec: 33-37.
Saadatian-Elahi M, Horstick O, Breiman RF, et al. Beyond effica-cy: The full public health impact of vaccines. Vaccine. 2016; 34(9): 1139-1147. doi: 10.1016/j.vaccine.2016.01.021
Lahariya C. Vaccine epidemiology: A review. J Family Med Prim Care. 2016; 5(1): 7-15. doi: 10.4103/2249-4863.184616
Verani JR, Baqui AH, Broome CV, et al. Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls. Vaccine. 2017; 35(25): 3295-3302. doi: 10.1016/j.vac-cine.2017.04.037
Wilder-Smith A, Longini I, Zuber P, et al. The public health val-ue of vaccines beyond efficacy: Methods, measures and outcomes. BMC medicine. 2017; 15(1): 138. doi: 10.1186/s12916-017-0911-8
Fox JP, Elveback LR. Herd immunity–changing concepts. Viral Immunology and Immunopathology. 1975; 273-290. doi: 10.1016/B978- 0-12-522050-7.50020-4
Fine PE. Herd immunity: History, theory, practice. Epidemi-ol Rev. 1993; 15(2): 265-302. doi: 10.1093/oxfordjournals.epirev. a036121
Halloran ME. The minicommunity design to assess indirect effects of vaccination. Epidemiol methods. 2012; 1(1): 83-105. doi: 10.1515/2161-962X.1008
Halloran ME, Longini IM. Struchiner CJ, Longini IM. Design and Analysis of Vaccine Studies. New York City, USA: Springer. 2010.
Shim E, Galvani AP. Distinguishing vaccine efficacy and ef-fectiveness. Vaccine. 2012; 30(47): 6700-6705. doi: 10.1016/j.vac-cine.2012.08.045 Submit your article to this journal | https://openventio.org/submit-manuscript/ 4 Dasgupta S
Halloran ME, Struchiner CJ. Causal inference in infectious dis-eases. Epidemiology. 1995; 6(2): 142-151.
Hudgens MG, Halloran ME. Toward causal inference with interference. J Am Stat Assoc. 2008; 103(482): 832-842. doi: 10.1198/016214508000000292
Vanderweele TJ, Tchetgen Tchetgen EJ. Effect partitioning un-der interference in two-stage randomized vaccine trials. Stat Probab Lett. 2011; 81(7): 861-869. doi: 10.1016/j.spl.2011.02.019
Halloran ME, Struchiner CJ. Study designs for dependent hap-penings. Epidemiology. 1991; 2(5): 331-338. doi: 10.1097/00001648- 199109000-00004
Gessner BD, Feikin DR. Vaccine preventable disease incidence as a complement to vaccine efficacy for setting vaccine policy. Vac-cine. 2014; 32(26): 3133-3138. doi: 10.1016/j.vaccine.2014.04.019
Dietz K. The estimation of the basic reproduction number for infectious diseases. Stat Methods Med Res. 1993; 2(1): 23-41. doi: 10.1177/096228029300200103
Rothman KJ, Greenland S, Lash TL, Greenland S. Modern Epi-demiology. Philadelphia, USA: Lippincott Williams & Wilkins. 2012.
Guerra FM, Bolotin S, Lim G, et al. The basic reproduction number (R ) of measles: A systematic review. Lancet Infect Dis. 2017; 17(12): e420-e428. doi: 10.1016/S1473-3099(17)30307-9
Fine P, Eames K, Heymann DL. Herd immunity: A rough guide. Clin Infect Dis. 2011; 52(7): 911-916. doi: 10.1093/cid/cir007
Hajjeh RA, Privor-Dumm L, Edmond K, et al. Supporting new vaccine introduction decisions: Lessons learned from the hib initi-ative experience. Vaccine. 2010; 28(43): 7123-7129. doi: 10.1016/j. vaccine.2010.07.028
Mahoney RT, Maynard JE. The introduction of new vaccines into developing countries. Vaccine. 1999; 17(7-8): 646-652.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Vaccination Research (VR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.